Omega Funds
Biotech Investor · 2 portfolio companies
Portfolio
2
Combined Value
$895.4M
Focus Areas
6
Top Stage
Phase 1/2
Investment Focus
Portfolio Companies
| Company | Valuation |
|---|---|
| enGene | $483.0M |
| Lexeo Therapeutics | $412.4M |
Biotech Investor · 2 portfolio companies
| Company | Valuation |
|---|---|
| enGene | $483.0M |
| Lexeo Therapeutics | $412.4M |